Nonetheless, the immuno-suppressive functions of the TGF-β family can eventually dominate the tumor microenvironment, ultimately promoting tumor growth by inhibiting cytotoxic CD8+ T lymphocytes (CTLs) and natural killer (NK) cells (18, 19). This evidence concerns the gene CD8A and neoplasm.